STOCK TITAN

Senseonics to Participate in the SVB Leerink Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Senseonics Holdings, Inc. (NYSE American: SENS) announced its participation in the virtual SVB Leerink Global Healthcare Conference on February 25, 2021, at 12:00 pm ET. The presentation will be accessible through the company's website under the 'Investor Relations' section. Senseonics specializes in developing long-term, implantable continuous glucose monitoring systems for diabetes patients, with products like Eversense® and Eversense® XL that provide timely glucose data directly to users' smartphones.

Positive
  • None.
Negative
  • None.

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming virtual SVB Leerink Global Healthcare Conference.

Management is scheduled to present Thursday, February 25, 2021 at 12:00 pm ET. Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com.

About Senseonics

Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of transformational glucose monitoring products designed to help people with diabetes confidently live their lives with ease. Senseonics' CGM systems, Eversense® and Eversense® XL, include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.

FAQ

What is Senseonics Holdings' stock symbol?

Senseonics Holdings' stock symbol is SENS.

When is Senseonics presenting at the SVB Leerink Global Healthcare Conference?

Senseonics is scheduled to present on February 25, 2021, at 12:00 pm ET.

How can I access the Senseonics presentation at the conference?

You can access the live and recorded webcast of the presentation on the 'Investor Relations' section of Senseonics' website.

What products does Senseonics offer for diabetes management?

Senseonics offers implantable continuous glucose monitoring systems, including Eversense® and Eversense® XL.

How does the Eversense CGM system work?

The Eversense CGM system consists of a small sensor inserted under the skin that sends glucose data to a smart transmitter and then to a mobile app every 5 minutes.

Senseonics Holdings, Inc.

NYSE:SENS

SENS Rankings

SENS Latest News

SENS Stock Data

287.78M
563.15M
4.86%
10.01%
6.64%
Medical Devices
Industrial Instruments for Measurement, Display, and Control
Link
United States of America
GERMANTOWN